Previsión
| Comprar |
0 |
| Mantener |
1 |
| Vender |
0 |
Debates en la comunidad
Traducido del alemán
¿Pagadores mensuales con buen dividendo?Me gustaría saber cuáles son los pagadores mensuales (ETFs o acciones) que tenéis y que tengan cierta solidez. En este momento estoy buscando opciones en el marco de mi reestructuración hacia una…
Sylvia V en Schnack 3 44
Noticias Ir al feed de noticias
Extendicare reports strong Q2 growth as acquisitions drive revenue and EBITDA
Extendicare posted Q2 revenue up 59.4% to C$611 million and adjusted EBITDA up 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, acquired Revera homes and Closing the Gap. CBI added C$145.7 million of revenue and C$18.5 million of adjusted EBITDA; management expects a methodical 18–24 month integration delivering C$7.4 million of annual cost synergies. The company refinanced debt, lowering its weighted-average interest rate to 4.4% and reducing pro forma leverage to about 2.5x, while advancing six long-term-care redevelopment projects and planning to add 832 beds across four openings in 2027. Home health volumes rose sharply but margins were modestly pressured by investment in technology and support functions; management expects longer-term volume growth of about 6–8% annually. » Más en finance.yahoo.com
Extendicare beats revenue forecasts, misses earnings and stock falls
Extendicare reported second-quarter 2026 revenue of 611 million CAD (+59.4%), well above expectations, while earnings of $0.319 per share missed the analyst estimate of $0.34. Adjusted EBITDA rose to 68.3 million CAD and adjusted results improved, but transaction, integration and refinancing costs weighed on net income. Management says the CBI integration is still in its early stages and expects 18–24 months for full integration, along with further investments in long-term care and home health. The stock fell about 8.7% in after-hours trading to $31.22 as investors put more weight on the earnings miss and near-term margin risks than on revenue growth. » Más en de.investing.com
Extendicare beats Q1 2026 earnings expectations by a wide margin and stock rises
Extendicare reported Q1 2026 EPS of 0.422 CAD, surpassing the analyst estimate of 0.2033 CAD by 107.6%. Revenue was 465.2 million CAD (+24.2% y/y), slightly below expectations, while adjusted EBITDA and AFFO rose markedly. Strong volume growth in the home-healthcare segment (32.7%) was driven by acquisitions and organic growth; the acquisition of CBI Home Health was completed. The stock climbed 10.84% after hours to 33.44 CAD; management continues to reaffirm ambitious profit and revenue guidance for 2026/2027. » Más en de.investing.com
Extendicare: stronger adjusted EBITDA from boom in home care, CBI acquisition creates national platform
Extendicare reported adjusted EBITDA of $44.2m for Q1 2026 (+52.2% year‑over‑year) and strong operational momentum driven by rapid volume growth in home care. Revenue rose to CAD 465.2m (below consensus), EPS materially beat expectations; AFFO per share climbed 55.9% to $0.276. In early April Extendicare completed the $570m acquisition of CBI Home Health, creating the leading home‑care platform in Canada and adding roughly $61.9m of adjusted EBITDA and 8,500 employees. To finance the deal the company issued $450m of unsecured senior notes, improving its capital structure; pro‑forma leverage is about 2.8x EBITDA. Management cites integration, labour shortages and timing of government funding as the main execution risks. » Más en de.investing.com
Extendicare completes acquisition of CBI Home Health for $570 million
Extendicare, through its subsidiary ParaMed, has completed the cash acquisition of CBI Home Health and related units for $570.0 million; estimated lease liabilities of about $13.6 million are additional. The transaction represents roughly 2% of Extendicare’s market capitalization and was funded by net proceeds from a private placement (≈$191.5 million), borrowings under senior secured credit facilities (≈$308.2 million) and cash. According to the data, the company reports a moderate leverage ratio of 0.27; Extendicare says the acquisition geographically and clinically complements its home‑health platform. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasEn 2026, EXTENDICARE INC. ya ha pagado 0,30 € en dividendos. El último pago fue en noviembre.
Datos financieros
En el último trimestre, EXTENDICARE INC. tuvo unos ingresos de 389,35 M € y un beneficio neto de 21,21 M €
| (EUR) | septiembre de 2026 | YoY |
|---|---|---|
| Ingresos | 389,35 M | 44,50 % |
| Beneficio bruto | 44,57 M | 30,28 % |
| Beneficio neto | 21,21 M | 43,67 % |
| EBITDA | 44,47 M | 49,68 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1603,29 M € |
Número de acciones | 88,37 M |
Máximo/mínimo de 52 semanas | 24,77 € - 13,02 € |
Rentabilidad por dividendo | 1,83 % |
Dividendos TTM | 0,35 € |
Próximo dividendo | 0,028 € |
Beta | 1,16 |
Ratio P/E | 20,46 |
Ratio PEG | 0,99 |
Ratio P/B | 6,38 |
Ratio P/S | 1,26 |
Perfil de la empresa
Extendicare Inc., a través de sus filiales, brinda atención y servicios para personas mayores en Canadá. La empresa ofrece servicios de cuidado a largo plazo (LTC); servicios de vida para la jubilación; y servicios de atención domiciliaria, como cuidados de enfermería, terapia ocupacional, física y del habla, y asistencia en las actividades diarias, así como servicios por contrato y de consultoría para terceros. Opera una red de 119 hogares de cuidado a largo plazo y comunidades de jubilación, así como operaciones de atención domiciliaria bajo las marcas Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist y SGP Purchasing Partner Network. Extendicare Inc. fue fundada en 1968 y tiene su sede en Markham, Canadá.
| Nombre | EXTENDICARE INC. |
| CEO | Michael R. Guerriere |
| Sede | Markham,
on Canadá |
| Sitio web | |
| Sector | Salud |
| Industria | Proveedores y servicios sanitarios |
| Salida a bolsa | 24/09/2012 |
| Empleados | 23.500 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Toronto Stock Exchange | EXE.TO |
Pnk | EXETF |
London Stock Exchange | 0S9E.L |
Frankfurt | 5XE.F |
Düsseldorf | 5XE.DU |
London | 0S9E.L |
München | 5XE.MU |